NCP Flanders
choose your programme
Horizon Europe

Horizon Europe is the main Research and Innovation Funding Programme of the European Commission.

Horizon 2020

Horizon 2020 is the previous Funding Programme. There are no longer calls, but projects can run until 2024.

Digital Europe

Digital Europe is a Funding Programme focused on bringing digital technology to businesses, citizens and administrations.

Other EU Funding

There are many other relevant EU funding programmes, managed by several agencies and directorates.


Personalised Medicine

Personalised Medicine

Partnership website:

This partnership aims to coordinate and promote research in the area of personalised medicine between the EU, EU countries and regions. The Partnership took off end of 2023. The first call for proposals is yet to be launched.

The European Partnership for Personalised Medicine (EP PerMed) aims to align and promote regional and national priority setting and funding for research and implementation projects in the field of personalised medicine among the EU Member States, regions and beyond. 

EP PerMed builds on over 15 years of EU-funded consortia, initiatives & events, but also on a wide range of national & European regional activities and efforts in all areas of the personalised medicine value continuum.

Key figures

  • Duration: 10 years
  • Total budget (national / regional plus EC contribution): Approximately 370 Mio. Euro
  • Partners: More than 50, mainly funding organisations from Europe and beyond

Participation Flanders

Grant Agreement negotiations for EP PerMed are ongoing. The participation of specific organisations will be announced after signing of the grant agreement.

The main objectives will be 

  • to ensure a faster uptake of research and innovation results into clinical practice, secure Europe's position in state-of-the-art healthcare provision
  • to facilitate a shift from a ‘one size fits all’ approach towards taking into account individual differences and better utilising the accumulating data to manage health, disease and its predisposition
  • to contribute towards more sustainable healthcare systems and independence in data intensive healthcare

Results will translate into delivery of better prevention and healthcare services, improved health outcomes for patients and citizens, and increased satisfaction with health systems.

Timeline & key documents

  • More information about the Partnership proposal (February 2022) 
  • In April 2023, the Strategic Research & Innovation Agenda for the Personalised Medicine Partnership was published. The SRIA will support a wide range of stakeholders and experts to further develop programs, activities, and research towards personalised medicine and care, as well as prevention.
  • In October 2023, during the Spanish Presidency conference on Personalised Medicine, a pre-launch ceremony of the partnership took place. The presentation is available here.
  • The Partnership is expected to be launched officially by the end of 2023

PerMed-related initiatives supporting EP PerMed

Within EP PerMed, several earlier European Initiatives are joined under one roof. It will continue the activities of ERA PerMed in funding transnational innovation and research projects. In addition, EP PerMed will closely together with the International Consortium for Personalised Medicine ICPerMed for overarching strategic activities.

'ICPerMed Family' of Coordination and Support Actions:


Commission services:
The Partnership:

What are partnerships?

Partnerships group the EC and private and/or public partners, to coordinate and streamline the research & innovation initiatives and funding in some selected key domains.

How to use partnerships?

  • orientation
    Partnerships publish strategic documents, e.g. outlining the main research and innovation challenges or key focus points.
  • networking
    Partnerships often organise events, such as info days, brokerage events, etc. Meet potential partners and learn about the nuances that are not visible in the official documents.
  • ecosystem analysis
    Partnerships typically have an advisory board, and publish impact studies of previous actions. These are good sources of information to uncover the main R&D&I players in the domain.
  • steering the agenda
    Partnerships collaborate with the EC on outlining the strategy and the future funding opportunities in their domain, based on input from industry, academia, and other stakeholders.


image of Luciad - Geospatial software for mission-critical operations

Luciad - Geospatial software for mission-critical operations

Founded in 1999, Luciad serves clients in Europe, Asia and the Americas. Though it recently was acquired by Hexagon Geospatial, they kept an agile SME mindset. Thousands of end users work directly with Luciad’s geospatial applications, and major systems integrators (think Airbus Defense and Space, Lufthansa Systems, NATO, Thales…) incorporate its software in their own products.

NCP Flanders went to Leuven to interview Frederic Houbie, the Research Projects Manager at Luciad, about how he sees Horizon 2020. Luciad is a partner in the MARISA project, which is a collaborative RIA project submitted to an ICT call topic